Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Buy
5,023
+2,498
+99% +$288K 0.02% 576
2026
Q1
$316K Buy
2,525
+282
+13% +$37K 0.01% 721
2025
Q4
$321K Buy
+2,243
New +$323K 0.01% 700
2017
Q4
Sell
-301
Closed -$19K 848
2017
Q3
$19K Buy
301
+31
+11% +$1.85K ﹤0.01% 484
2017
Q2
$15K Buy
270
+180
+200% +$9.37K ﹤0.01% 484
2017
Q1
$4K Hold
90
﹤0.01% 604
2016
Q4
$4K Hold
90
﹤0.01% 604
2016
Q3
$5K Hold
90
﹤0.01% 604
2016
Q2
$4K Hold
90
﹤0.01% 635
2016
Q1
$4K Hold
90
﹤0.01% 567
2015
Q4
$3K Hold
90
﹤0.01% 361
2015
Q3
$3K Buy
+90
New +$3.03K ﹤0.01% 525

Other funds holding XYL

Krilogy Financial's XYL Position: Q2 2026 in Review

Krilogy Financial increased its Xylem (XYL) stake by 99% in Q2 2026, buying an estimated $288K and bringing the position to 5,023 shares worth $594K. The position accounts for 0.02% of the portfolio, ranked #576.

Krilogy Financial first reported a position in XYL in Q3 2015 and has held it in 12 quarters since. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Krilogy Financial held 5,023 shares of Xylem worth $594K as of Q2 2026.
  • Krilogy Financial bought 2,498 Xylem shares in Q2 2026, an estimated $288K.
  • Xylem made up 0.02% of Krilogy Financial's portfolio in Q2 2026, its #576 holding.
  • Krilogy Financial first reported a position in Xylem in Q3 2015 and has held it in 12 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.